Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

71.20
Delayed Data
As of 3:59pm ET
 -0.76 / -1.06%
Today’s Change
16.61
Today|||52-Week Range
99.45
+60.29%
Year-to-Date
AstraZeneca/Merck's Lynparza Gets FDA Nod for Label Expansion
Aug 18 / Zacks.com - Paid Partner Content
Clovis (CLVS) Focuses on Label Expansion, Rubraca Impresses
Aug 15 / Zacks.com - Paid Partner Content